1. ApoE4转基因模型中PU.1-LRP1信号调节小胶质细胞自噬的AD机制研究，河南省自然科学基金项目，2025.01-2026.12，主持

2. 山茱萸活性成分马钱苷调控线粒体自噬-神经炎症改善 AD 的作用及机制研究, 河南省重点研发与推广专项（科技攻关）项目，2023.01-2024.12，主持

3. ApoE4介导转基因小鼠炎症反应的AD发病机制研究, 国家自然科学基金委员会面上项目，2019.01-2022.12，参与

4. 基于网络药理学和多组分敲除技术的藜芦生物碱降压机制研究, 国家自然科学基金委员会联合基金项目, 2021.01-2023.12，参与

1. Natural products that alleviate depression: The putative role of autophagy, Pharmacology & Therapeutics, 2024, 264:108731.

2. A review of matrix metalloproteinase-2-sensitive nanoparticles as a novel drug delivery for tumor therapy, International Journal of Biological Macromolecules, 2024, 262(2):130043.

3. A new andrographolide derivative ADA targeting SIRT3-FOXO3a signaling mitigates cognitive impairment by activating mitophagy and inhibiting neuroinflammation in Apoe4 mice, Phytomedicine, 2024,124:155298.

4. Myricetin improves pathological changes in 3×Tg-AD mice by regulating the mitochondria-NLRP3 inflammasome-microglia channel by targeting P38 MAPK signaling pathway, Phytomedicine , 2023,115:154801.

5. Luteolin alleviates cognitive impairment in Alzheimer’s disease mouse model via inhibiting endoplasmic reticulum stress-dependent neuroinflammation. Acta Pharmacologica Sinica, 2022, 43(4):840-849.